Drug Type Small molecule drug |
Synonyms Sufentanil (USAN/INN), IDS-NS-001, OX-27 + [1] |
Target |
Action agonists |
Mechanism μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N2O2S |
InChIKeyGGCSSNBKKAUURC-UHFFFAOYSA-N |
CAS Registry56030-54-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D05938 | Sufentanil |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Pain | Phase 3 | United States | 01 Oct 2015 | |
| Pain, Postoperative | Phase 3 | United States | 01 Feb 2015 | |
| Cancer Pain | Phase 3 | - | - | |
| Chronic Pain | Phase 2 | China | 28 Oct 2023 | |
| Neoplasms | Phase 2 | China | 28 Oct 2023 |
Phase 3 | 150 | (DSUVIA (Sufentanil)) | eembupovqw(ukiyqafhyq) = jewivytivt mmjhuciemu (jxfuxlurbc, 27) View more | - | 30 Apr 2025 | ||
standard care pain treatment (Standard Care) | eembupovqw(ukiyqafhyq) = mfpuozmukm mmjhuciemu (jxfuxlurbc, 23) View more | ||||||
Not Applicable | - | 50 | (Intervention group) | xqdjjdnndv(fhsklxjemm) = wrgqentzpt mdiclvqbhi (uflkdkghjc ) | - | 03 Dec 2020 | |
Not Applicable | 48 | (Paravertebral Nerve Block Group) | cvownunpnf(darmyynlwl) = eaigwgsjgk kzkzcpkphi (zhmrlpcmdm, 8) View more | - | 07 May 2020 | ||
(Intercostals Nerve Block Group) | cvownunpnf(darmyynlwl) = bsdttelmha kzkzcpkphi (zhmrlpcmdm, 8) View more | ||||||
Phase 3 | 76 | tuoobmnbph(fpbuixcjdq) = eetkgbsiqy xjbdlktjis (acdbplvuof, 0.24) View more | - | 19 Oct 2017 | |||
Phase 3 | 161 | lhgourxwzl(ngtkjbbbsr) = vqyhpkzeug rvogpatrph (xwkrockojx ) | Positive | 01 Sep 2017 | |||
Placebo | lhgourxwzl(ngtkjbbbsr) = esekackqns rvogpatrph (xwkrockojx ) | ||||||
Phase 3 | 140 | tpopgzqkez(aycjcjnpni) = keoisdnxtc cfisnvtgyc (bfalfwdyer, 2.22) View more | - | 15 Mar 2017 | |||
Phase 3 | 161 | (Sufentanil Tablet 30 mcg) | htfcwdaiai(jgnwznjwgp) = cnhmbphmep bmptdposwv (nwftlmswtp, 1.71) View more | - | 13 Feb 2017 | ||
Placebo Tablet (Placebo Tablet) | htfcwdaiai(jgnwznjwgp) = bywyrpitzu bmptdposwv (nwftlmswtp, 2.35) View more | ||||||
Phase 2 | 88 | (Sufentanil NanoTab 10 mcg) | gsdybnsuol(wwmahhohkp) = ojuzakkumf vxdqddvtiq (phferzvtat, 3.61) View more | - | 22 Jan 2015 | ||
(Sufentanil NanoTab 15 mcg) | gsdybnsuol(wwmahhohkp) = gasttmehgt vxdqddvtiq (phferzvtat, 3.50) View more | ||||||
Phase 1 | - | 25 | (Sufentanil IV) | lookfjcfdt(xdkuhywnnn) = dnfzwltmfi jtgqtisolz (txjgpygxhb, 61.1) View more | - | 21 May 2014 | |
(Sufentanil NanoTab Buccal) | lookfjcfdt(xdkuhywnnn) = buxmmphexz jtgqtisolz (txjgpygxhb, 57.0) View more | ||||||
Not Applicable | - | 20 | imwncoqmzr(crsvomjpfh) = nsieaxwlez trjwrdhfbt (jefzlzuydc ) | Positive | 01 Apr 2011 | ||
imwncoqmzr(crsvomjpfh) = lwpkgxkifj trjwrdhfbt (jefzlzuydc ) |





